Article Information
History
- July 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniel Re, MD, PhD1,&,
- Barbara Seitz-Polski, MD, PhD2,
- Michel Carles, MD., Ph D.3,
- Vesna Brglez, PhD2,
- Daisy Graça4,
- Sylvia Benzaken, MD4,
- Stéphane Liguori, MD5,
- Khaled Zahreddine, MD5,
- Margaux Delforge, PharmD6,
- Benjamin Verrière, PharmD6,
- Emmanuel Chamorey, PharmD., PhD7 and
- Barrière Jérôme, MD.8,&
- 1Department of Hematology and Medical Oncology, Centre Hospitalier Antibes-Juan les Pins, 107 Route de Nice, 06600 Antibes, FRANCE
- 2Laboratoire d’Immunologie, Centre Hospitalier Universitaire (CHU) de Nice, Université Côte d’Azur, Nice, France
- 3Department of infectious disease, Centre Hospitalo-Universitaire de Nice, ARCHET 1 06000 NICE, France
- 4Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d’Azur, Nice, France
- 5Department of Medical Biology, Centre Hospitalier, Antibes, France
- 6Department of Pharmacy, Centre Hospitalier, Antibes, France
- 7Department of Biostatistics and Epidemiology., Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
- 8Department of Medical Oncology, Polyclinique Saint Jean, 92 avenue Dr Donat, 06800 Cagnes-sur-Mer, France
- ↵&Corresponding Authors: Dr Daniel Re daniel.re{at}ch-antibes.fr and Dr Jérôme Barrière j.barriere{at}polesantesaintjean.fr Corresponding Author:
Dr Barrière Jérôme, Department of medical oncology, Clinique Saint Jean, 92 avenue Dr Donat, 06800 CAGNES-SUR-MER, FRANCE, j.barriere{at}polesantesaintjean.fr
* Authors contributed equally to this work
Author Contributions: Drs Re, Seitz-Polski, Chamorey and Barrière had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Additional Contributions: We acknowledge all nurses of the day clinic of the Antibes Hospital (Elodie, Laurence, Nicole, Vinaj, and Valérie) and more specifically Sylvie Andreo who was responable for the administration of dose 3 and for the management of blood sampling. We last acknowledge patients for their participation.
Posted July 22, 2021.
Humoral and cellular responses after a third dose of BNT162b2 vaccine in patients treated for lymphoid malignancies
